OR WAIT null SECS
December 02, 2005
First, a confession. Yes, the four sleep-deprived editors hunched behind glowing laptops in the Opryland Resort's Cyber Café last month were indeed from this publication. Normally, our mumbled conversations about punctuation and grammar take place before 11:00 pm—and under slightly lower systemic levels of caffeine, sugar, and sushi.
December 01, 2005
The attraction of nasal administered therapeutic agents is obvious, including faster onset of action, increased compliance and avoiding degradation during first pass metabolism.
November 02, 2005
"It was just after FDA had initiated the Pre-Approval Inspection process," reports our GMP Agent-in-Place.
Oddly for a technical meeting, the Oct. 5–7 AAPS Workshop on Pharmaceutical Quality Assessment focused on words, with an entire session devoted to definitions and countless discussions of meaning and nuance.
As industry moves to real-time feedback control, even conventional syntheses will increasingly resemble living systems.
The pharmaceutical industry can leverage best practices from the extremely competitive semiconductor market.
November 01, 2005
Recent advances in transdermal technologies challenge the paradigm that only a few drugs can be delivered transdermally.
The EU ATEX Directive 1999/92/EC (ATEX 137) regarding the minimum requirements to protect the health and safety of workers potentially at risk from explosive atmospheres came into European law in January 2000. In the UK, the ATEX 137 Directive has been implemented as part of the Dangerous Substances and Explosive Atmospheres Regulations (DSEARs), which were issued in December 2002.
The human race will have colonized Mars long before the pharmaceutical industry brings itself into the 21st century.
Biomanufacturing managers believe the current lack of adequately trained personnel is one of the most serious problems facing the biomanufacturing industry.